Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bowman-Birk inhibitor product for use as an anticarcinogenesis agent

Bowman-Birk inhibitor product for use as an anticarcinogenesis agent

US Patent 5338547 · Granted Aug 16, 1994

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle diseas2014
Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degener2011
Bowman-Birk inhibitor soy protein concentrate composition2008
Use of Bowman Birk inhibitor for the treatment of multiple sclerosis and other a2007
Method of making Bowman-Birk inhibitor product2005
Use of bowman birk inhibitor for the treatment of multiple sclerosis and other a2004
Bowman-birk inhibitor compositions and methods for the treatment of genitourinar1999
Method of monitoring exposure to Bowman Birk inhibitor using monoclonal antibodi1997
Monoclonal antibodies differentially reactive with native and reductively modifi1997
Bowman-Birk Inhibitor compositions for treatment of inflammatory disease1997
Bowman-birk inhibitor concentrate compositions and methods for the treatment of 1996
Bowman-birk inhibitor concentrate compositions and methods for the treatment of 1996